---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-006760"
form_type: "8-K"
ticker: "PAHC"
cik: "0001069899"
company_name: "PHIBRO ANIMAL HEALTH CORP"
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T06:50:55.914736+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Phibro Animal Health Q3 net sales up 32% to $347.8M; Adj EBITDA +85%; raises FY2025 guidance

## Summary
- Q3 net sales $347.8M (+32% YoY); net income $20.9M (+$12.5M); diluted EPS $0.51 (+$0.30).
- Adjusted EBITDA $54.9M (+85% YoY); adjusted diluted EPS $0.63 (+$0.32).
- Animal Health segment sales +42% driven by Zoetis MFA acquisition; legacy Animal Health flat.
- Updated FY2025 guidance: net sales $1.26B-$1.29B, Adj EBITDA $177M-$183M (62% growth at midpoint).
- Gross leverage ratio 3.0x; free cash flow $49.1M for trailing twelve months.

## SEC filing metadata
- accession: 0001558370-25-006760
- form_type: 8-K
- ticker: PAHC
- cik: 0001069899
- company_name: PHIBRO ANIMAL HEALTH CORP
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069899/000155837025006760/0001558370-25-006760-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069899/000155837025006760/pahc-20250507x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-006760
- JSON: https://secwatch.observer/filing/0001558370-25-006760.json
- Plain text: https://secwatch.observer/filing/0001558370-25-006760.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.